Compound Screening TRIZ Cases

Measuring ISG15 biomarkers resolves diagnostic inaccuracy for chronic neurodegenerative diseases.

A cell-free protein synthesis system quantifies amino acids by measuring synthesized protein signal intensity against standard curves.

A recombinant cell platform replicates nociceptive features to evaluate drug candidates via electrophysiological and transcriptomic assays.

Fluorescent chemical probes bind directly to the mycobacterial transporter MmpL3, enabling rapid detection of inhibitor interactions via optical signals.

An aerosol exposure cap delivers uniform fluid flow to model materials for precise in vitro respiratory testing.

Suppressing SHP-1/-2 or FcγRIIB reduces alpha-synuclein propagation, addressing the lack of effective mechanisms for neurodegenerative disease progression.

Modified AAV capsids bind Ly6 surface proteins to enable transcytosis across the blood-brain barrier.

A recombinant fusion construct links a cytotoxic element to a protein of interest, enabling positive selection of destabilizing agents through increased cell viability.

Measuring FOXP3 Zinc-LeuZip domain oligomerization identifies chemical candidates that modulate immune responses.

Spatially controlled myotube culture resolves species discrepancies in neuromuscular disease modeling by enabling automated functional readouts.

A magnetic force spectroscopy system measures dissociation forces on ligand-receptor complexes to quantify binding strength.

A surrogate virus neutralization assay kit uses conjugated spike protein to detect neutralizing antibodies.

Elastase 2A inhibitors block protease activity to restore intestinal barrier function and mitigate inflammation.

An ERAP1-derived peptide blocks PHB2 binding to suppress estrogen receptor activation.

Segment glycyl-tRNA synthetase into functional domains to measure cadherin binding affinity, identifying cancer agents that modulate this interaction.

AlphaScreen assays identify YKL-40 inhibitors by detecting luminescent bead proximity, reducing screening complexity while maintaining high throughput.

BLR-200 peptide targets CCN pathways to reverse skin fibrosis without invasive biopsies.

A mesh patch with micro-cavities holds labeling substances to detect target analytes, eliminating washing steps that consume large specimen volumes.

A method producing mature hepatocytes using defined transcription factors to induce functional cell phenotypes.

Optimizing linker length and warhead reactivity achieves isoform-selective PI3Kα inhibition while reducing adverse side effects from pan-isoform activity.

Small molecules form hydrogen bonds with asparagine residues and Van der Waals interactions within lipophilic pockets to bind bromodomains.

Targeted peptide inhibitors suppress Drp1-mediated fission, reducing oxidative stress and cell death in neurodegenerative disease models.

Cyclic pentapeptide and hexapeptide analogs of endomorphins improve solubility while reducing respiratory depression and abuse liability.

Chaperonins bind target proteins to identify stabilizers, eliminating heat-induced artifacts common in thermal denaturation assays.

Targeting RBMS2 resolves the contradiction between broad symptom relief and precise molecular intervention in immune disease management.

A microfabricated chamber enables high-throughput skin sensitization detection by co-culturing antigen-presenting cells with skin tissue.

R2 fragment seeds induce Tau aggregation, replicating native PHF characteristics for inhibitor screening.

A blood test detects hepatic fibrosis by measuring lipid transfer inhibitor protein levels in plasma samples.

Electrospun PLGA-mPEG scaffolds induce tumoroid formation to replicate native extracellular matrix architecture.

Modified RAMP2 polypeptides enhance adrenomedullin receptor affinity, extending half-life and stability for metabolic syndrome treatment.

Segmented screening and extraction of BRDT antigens resolve prediction accuracy trade-offs while minimizing off-target toxicity.

Small molecule ligands stabilize the RyR2 channel in a closed conformation, preventing pathological calcium leaks caused by inherited mutations.

Modulating serum lipid ratios and inhibiting uptake mechanisms overcomes metabolic flexibility resistance to SCD1 inhibition.

Segmented linked peptides target the gp41 N-trimer pocket, reducing dosing requirements and cost while maintaining potent HIV entry inhibition.

Near-infrared water spectroscopy extracts molecular interaction fingerprints under controlled temperature changes.

A recombinant SARS-CoV-2 assay measures cross-neutralization titers against the Omicron variant using fluorescent reporter proteins.

Combines metformin with piperazine derivatives to inhibit gluconeogenesis and stimulate glucose consumption.

MK2 kinase inhibitors use covalent warhead groups to bind cysteine residues and irreversibly block enzyme activity.

A phage display method accelerates selection cycles by immobilizing targets and performing rapid in-situ amplification.